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Alternative pre-mRNA splicing plays a major role in expanding the transcript output of human genes. This process is
regulated, in part, by the interplay of trans-acting RNA binding proteins (RBPs) with myriad cis-regulatory elements scat-
tered throughout pre-mRNAs. These molecular recognition events are critical for defining the protein-coding sequences
(exons) within pre-mRNAs and directing spliceosome assembly on noncoding regions (introns). One of the earliest events
in this process is recognition of the 3′ splice site (3′ss) by U2 small nuclear RNA auxiliary factor 2 (U2AF2). Splicing reg-
ulators, such as the heterogeneous nuclear ribonucleoprotein A1 (HNRNPA1), influence spliceosome assembly both in vitro
and in vivo, but their mechanisms of action remain poorly described on a global scale. HNRNPA1 also promotes proofread-
ing of 3′ss sequences though a direct interaction with the U2AF heterodimer. To determine how HNRNPA1 regulates
U2AF–RNA interactions in vivo, we analyzed U2AF2 RNAbinding specificity using individual-nucleotide resolution cross-
linking immunoprecipitation (iCLIP) in control and HNRNPA1 overexpression cells. We observed changes in the distribu-
tion of U2AF2 crosslinking sites relative to the 3′ss of alternative cassette exons but not constitutive exons upon HNRNPA1
overexpression. A subset of these events shows a concomitant increase of U2AF2 crosslinking at distal intronic regions,
suggesting a shift of U2AF2 to “decoy” binding sites. Of the many noncanonical U2AF2 binding sites, Alu-derived RNA
sequences represented one of the most abundant classes of HNRNPA1-dependent decoys. We propose that one way
HNRNPA1 regulates exon definition is to modulate the interaction of U2AF2 with decoy or bona fide 3′ss.
[Supplemental material is available for this article.]
Precursor messenger RNA (pre-mRNA) splicing is catalyzed by a
large macromolecular complex composed of five uridine-rich
small nuclear ribonucleoprotein particles (U snRNPs) and myriad
protein factors (Wahl et al. 2009). This process is required to excise
intervening sequences (introns) from the pre-mRNA and ligate
protein-coding sequences (exons). The 5′ and 3′ ends of introns
are defined by nearly invariant GU and AG dinucleotides as well
as the branch point sequence, respectively. Combinatorial pro-
tein–RNA interactions play important roles in defining the splice
sites and branch point during spliceosome assembly. The 5′ splice
site (GU) is recognized by serine and arginine-rich splicing factors
(SR Proteins) and through base-pairing interactions with the U1
snRNP (Eperon et al. 1993; Jamison et al. 1995). Similarly, the 3′
splice site (3′ss) is decoded by a combination of SR proteins and
the U2 snRNP auxiliary factor (U2AF). After early (E) complex
assembly, the branch point sequencing is specified through the
interaction of U2AF, splicing factor 1 (SF1), and via base-pairing
with the U2 snRNP (Ruskin et al. 1988; Berglund et al. 1997). The
responsibility for 3′ss recognition is shared by the two subunits
of U2AF (Merendino et al. 1999; Wu et al. 1999; Zorio and
Blumenthal 1999). The small and large subunits of U2AF, encoded
by U2AF1 and U2AF2, recognize the AG dinucleotide and the
upstream polypyrimidine tract, respectively (Merendino et al.
1999; Wu et al. 1999; Zorio and Blumenthal 1999). These early
steps in spliceosome assembly play critical roles in defining
exon–intron boundaries.
HNRNPA1 is a well-characterized regulator of alternative
splicing. One of the primary functions of HNRNPA1 is to prevent
inclusion of specific exons (Mayeda and Krainer 1992; Caceres
et al. 1994; Yang et al. 1994). Several models for HNRNPA1-depen-
dent exon skipping have been described in the literature. For
example, HNRNPA1 can compete with RBPs for binding to juxta-
posed regulatory elements that would be normally occupied by
splicing enhancer proteins such as SRSF1 (Eperon et al. 2000;
Zahler et al. 2004). Another potential mechanism involves oligo-
merization and spreading of HNRNPA1 from an exonic splicing
silencer across a regulated exon, thus antagonizing binding of
splicing enhancers and spliceosomal factors, such as U2AF2 (Zhu
et al. 2001; Okunola and Krainer 2009). Finally, HNRNPA1 bind-
ing to intronic splicing silencers on either side of an alternative
exon can dimerize, causing “looping out” of an exon from the
pre-mRNA, and promote its exclusion from the final mature tran-
script (Blanchette and Chabot 1999). A related alternative splicing
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factor, PTBP1, also promotes exon skipping via a looping mecha-
nism (Chou et al. 2000; Lamichhane et al. 2010). Perhaps most
relevant to this work, HNRNPA1 promotes proofreading of the
3′ss by U2AF2. In this case HNRNPA1 enables the U2AF hetero-
dimer to reject suboptimal splice sites (Tavanez et al. 2012). In
light of these diverse molecular mechanisms of HNRNPA1-depen-
dent splicing regulation, there is a critical need to test their gener-
ality on a global scale.
In this study, we investigate how HNRNPA1 influences the
association of U2AF2 with 3′ss on a transcriptome-wide scale.
We used individual nucleotide resolution crosslinking immuno-
precipitation (iCLIP) and high-throughput sequencing to map
U2AF2–RNA interactions in control or HNRNPA1 overexpression
cell lines. As HNRNPA1 has been shown to be overexpressed in a
variety of cancer types (Ushigome et al. 2005; Boukakis et al.
2010; Zhou et al. 2013) and directly involved in specific splicing
event that regulate disease phenotype (David et al. 2010; Chen
et al. 2012; Bonomi et al. 2013; Loh et al. 2015), this in-cell model
will allow us a global look at the effects of HNRNPA1 modulation
on splicing and RBP distribution.
Results
To determine how HNRNPA1 influences
the association of U2AF2 with 3′ss
on a global scale, we established an
HNRNPA1-inducible expression system
in HEK293 cells. We then assayed
U2AF2 and HNRNPA1 protein–RNA
interactions in control or HNRNPA1
overexpression cells using individual nu-
cleotide resolution crosslinking immu-
noprecipitation and high throughput
sequencing (iCLIP-seq) (Konig et al.
2010). We favored the overexpression
approach because HNRNPA1 protein
levels are elevated in many human can-
cers (Pino et al. 2003; Ushigome et al.
2005; Chen et al. 2010; Loh et al. 2015;
Yu et al. 2015). Induction of HNRNPA1
results in an approximately twofold
increase compared to the endogenous
protein (and relative to EWSR1) and has
no appreciable effect on SRSF1 or U2AF2
steady-state protein levels (Fig. 1A).
We used iCLIP to purify HNRNPA1–,
SRSF1–, andU2AF2–RNAcomplexes from
control and HNRNPA1 overexpressing
cells (Fig. 1B; Supplemental Fig. S2A,B).
In all cases, the immunoprecipitated
material was both UV- and antibody-
dependent, nuclease-sensitive, and pro-
duced robust sequencing libraries
(Supplemental Tables 1–3). After identi-
fication of binding site peaks using
CLIPper (Supplemental Table 4; Lovci
et al. 2013), we observed differences
in the distribution of U2AF2 peaks across
genomic locations between control and
HNRNPA1 overexpression cell lines (Fig.
1C). Most notably, the proportion of
peaks located in coding exons (CDS) or
in exon-proximal intronic regions was
reduced, whereas intronic peaks located >500 nucleotides (nt)
from exons (distal intron) increased. A similar trend was observed
for SRSF1 peaks (Supplemental Fig. 1). In both control cells and
HNRNPA1 overexpression cells, intragenic, non-repeat-associated
U2AF2 peaks are characterized by a pyrimidine-rich motif, closely
resembling authentic 3′ss (Figs. 1D, 2E). Although the sequences
are distinct from each other, SRSF1 and HNRNPA1 motifs also
appear tobe similarbetweencontrol andHNRNPA1overexpression
cells (Supplemental Fig. 1A,B).
To understand how HNRNPA1 overexpression alters U2AF2–
RNA interactions, we identified differentially occupied binding
sites in the two cell lines. The union of U2AF2 binding sites from
control and HNRNPA1 overexpression cells consisted of nearly
307,000 peaks (Supplemental Tables 5, 6). The majority of these
sites (66.3%) were unaffected by HNRNPA1 overexpression (Figs.
1E, 2D). In contrast, 21.5% and 12.2% of U2AF2 binding sites
exhibited significant decreases or increases in crosslinking, respec-
tively, upon HNRNPA1 overexpression (Supplemental Table 5).
We used BEDTools along with GENCODE and RepeatMasker
(Tarailo-Graovac and Chen 2009; Quinlan and Hall 2010;
BA
EC
D
Figure 1. Crosslinking immunoprecipitation of U2AF2 under HNRNPA1 modulation. (A) Western blot
analysis of SRSF1, U2AF2, HNRNPA1, the T7 epitope, and EWSR1 in control (lane 1) and HNRNPA1 over-
expression HEK293 cells. (B) Examples of iCLIP autoradiographs for U2AF2 either in control or following
overexpression of HNRNPA1. Protein–RNA complex shifts are UV-, antibody-, andmicrococcal-nuclease–
sensitive. Bars denote the region of nitrocellulose blot excised for RNA isolation for iCLIP library prepara-
tion. Micrococcal nuclease treatment at 15 U (high) and 0.015 U (low). (C) CLIPper analysis of iCLIP RNA
distribution for U2AF2 in control and HNRNPA1 overexpression conditions. (D) Top HOMER consensus
binding motifs for U2AF2 in control and HNRNPA1 overexpression conditions in peaks that do not over-
lap repetitive elements. (E) Proportion of U2AF2 binding site peaks lost (green), gained (red), or un-
changed (blue) in HNRNPA1 overexpression cells.
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Wright et al. 2016) to annotate peaks
with significantly different U2AF2 cross-
linking in control and HNRNPA1 overex-
pression cells. U2AF2 peaks that were lost
after HNRNPA1 overexpression were
enriched for 3′ss annotations (P < 2.2 ×
10−16, χ2 test of independence), whereas
peaks gained showed a strong preference
for Alu-derived RNA sequences (P < 2.2 ×
10−16, χ2 test of independence) (Fig. 2A–
C; Supplemental Fig. 2A). Like U2AF2
peaks, SRSF1 binding sites were also per-
turbed by HNRNPA1 overexpression,
but they exhibit the opposite trend with
respect to 3′ss (Supplemental Table 7)
and Alu-derived RNA sequences (Fig.
2D; Supplemental Fig. 2B,C).
To determine if HNRNPA1 alters
the sequence landscape of U2AF2–
RNA interactions, we searched for over-
represented sequences in both stable
and differential peaks in control and
HNRNPA1 overexpression cells. We clas-
sified U2AF2 peaks into three groups:
those overlapping Alu-derived sequenc-
es, those overlapping 3′ss and “other”
sequences, for peaks not part of either
class. For each group, we identified en-
riched sequences from lost, gained, or
stable (static) peaks, resulting in nine
different classes of U2AF2 binding sites.
For most classes, we observe variations
of pyrimidine-rich sequences that resem-
ble 3′ss. For example, Figure 2E shows
the top three exemplar motifs from sta-
ble, HNRNPA1-promoted, or HNRNPA1-
disrupted U2AF2 peaks annotated as
3′ss. For the 13,986 stable peaks at 3′ss,
∼26% contained the most highly en-
riched motif shown in Figure 2E (P <
10−155). In contrast, at 3′ss peaks that
were disrupted in HNRNPA1 overexpres-
sion cells, a distinct pyrimidine-rich
motif was discovered in ∼31% of 13,318
peaks (P < 10−159). Amuch smaller subset
of peaks exhibited increased U2AF2
crosslinking in the overexpression cells
relative to control. Of these 867 binding
sites, 9.6% contained the strong polypyr-
imidine motif (P < 10−16), which closely
resembled the static sites. Although poly-
pyrimidine-rich motifs are present in
the majority of 3′ss and “other” binding
sites, peaks annotated as overlapping
Alu elements are less pyrimidine-rich
(Fig. 2E). These data suggest that Alu-de-
rived sequences are an abundant class
of noncanonical binding motif that be-
come accessible to U2AF2 in HNRNPA1
overexpression cells.
HNRNPA1 influences association of
splicing factors such as U2AF2 with 3′ss
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Figure 2. Analysis of global changes in U2AF2 binding site and consensus motifs in control and
HNRNPA1 overexpression cells. (A) Volcano plot representing the log2(fold-change) in U2AF2 crosslink-
ing peaks (HNRNPA1 overexpression/control) found within Alu elements, 3′ splice site regions, both Alu
and 3′ splice site regions (both), or other regions outside of these (other). These fold-changes are plotted
against their corresponding –log10(adjusted P-value) associated with each fold-change. Horizontal dot-
ted lines are associated with a log2(fold-change) of ±2 and between HNRNPA1 overexpression versus
control samples. Vertical dotted lines are associated with −log10(adjusted P-value) corresponding to
0.05. (B) Stacked bar graph showing the proportion of U2AF2 crosslinking peaks showing no change
(top), increased crosslinking peaks (Increased Binding), or decreased crosslinking peaks (Decreased
Binding) found within Alu elements, 3′ splice site regions, both Alu and 3′ splice site regions (both), or
other regions outside of these (other). (C) Stacked bar graph showing the total count of U2AF2 crosslink-
ing peaks showing no change (top), increased crosslinking peaks (Increased Binding), or decreased cross-
linking peaks (Decreased Binding) found within Alu elements, 3′ splice site regions, both Alu and 3′ splice
site regions (both), or other regions outside of these (other). (D) Volcano plot representing the log2(fold-
change) in SRSF1 crosslinking peaks found within Alu elements, 3′ splice site regions, both Alu and 3′
splice site regions (both), or other regions outside of these (other). (E) HOMER-generated exemplar
U2AF2motifs associated with static (left), HNRNPA1-disrupted (middle), and HNRNPA1-promoted (right)
crosslinking peaks at 3′ splice sites with HNRNPA1 overexpression. Associated P-values for each motif are
provided in parentheses.
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on a case-by-case basis (Zhu et al. 2001; Tavanez et al. 2012).
However, its effects on splicing-factor RNA targeting on a global
scale are not well defined. In order to assess the effects of
HNRNPA1 on transcriptome-wide splicing, we determined how
titration of HNRNPA1 affected the distribution of SRSF1– and
U2AF2–RNA crosslinks relative to 3′ss of constitutive or alternative
cassette exons. As suggested by the peak analysis (Supplemental
Fig. 3), there are no differences in HNRNPA1 crosslinking sites be-
tween control and overexpression cells (Supplemental Fig. 4A,B,
left panels, blue and red lines, respectively). SRSF1 crosslinking
to exonic sequences was modestly reduced in the HNRNPA1 over-
expression cells compared to control, but the positional distribu-
tion of the SRSF1 sites relative to the 3′ss was largely unchanged
for constitutive and skipped exons (Supplemental Fig. 4A,B, right
panels, blue and red lines, respectively). U2AF2 crosslinking
distribution relative to the 3′ss was substantially altered in
HNRNPA1 overexpressing cells compared to the control, where a
characteristic peak is observed over the 3′ss of both constitutive
and skipped exons (Fig. 3A,B, blue line). In contrast, in cells over-
expressingHNRNPA1, U2AF2 crosslinking density near alternative
exons shifts downstream from the 3′ss and the peak is substantially
reduced (Fig. 3B right panel, red line). To further determine if there
is a direct relationship between HNRNPA1 binding and changes in
U2AF2 or SRSF1 association with transcripts, we examined regions
flanking the 3′ss of skipped exons with HNRNPA1 crosslinking in
either condition (Fig. 3C; Supplemental Fig. 4C; Supplemental
Tables 5–7). In regions with no detectable HNRNPA1 crosslinks,
the change in U2AF2 crosslinking exhibits a bimodal distribu-
tion, which corresponds to regions flanking the 3′ss that show ei-
ther increased or decreased U2AF2 crosslinking in HNRNPA1
overexpression cells relative to control cells (Fig. 3C, blue). In con-
trast, U2AF2 crosslinking to the vicinity of the 3′ss is significantly
reduced when a direct association of HNRNPA1 is also evident
(Fig. 3C, pink). For example, in both SRSF6 (serine/arginine-rich
splicing factor 6 also known as SRP55) and PIEZO1 (piezo type
mechanosensitive ion channel component 1), we found that
U2AF2 crosslinking near the 3′ss is reduced in the cell lines over-
expressing HNRNPA1 (Supplemental Fig. 5).
Previous work by Zarnack et al. (2013) demonstrated that
HNRNPproteins, such as HNRNPC, competewithU2AF2 for bind-
ing to antisenseAlu elements, in order to repress their exonization.
We asked if HNRNPA1 similarly repressed U2AF2 crosslink-
ing to Alu elements by measuring crosslink density across the
boundaries of intronic Alu elements in control and HNRNPA1
overexpression cells. We observed a dramatic increase in U2AF2
crosslinking to Alu-containing RNA transcripts compared to con-
trol cells (Fig. 4A,B; Supplemental Tables 8–11). Like prior reports
(Supplemental Table 8), U2AF2 crosslink density was nearly
10-fold greater in RNA derived from antisense Alu elements com-
pared to sense (cf. Fig. 4A to B; Zarnack et al. 2013; Shao et al.
2014). To visualize HNRNPA1-dependent accumulation of
U2AF2 in Alu elements, we calculated the coverage of all peaks
across a consensus sequence assembled from all the Alu subtypes
in the human genome (see Methods). For example, for subtype
AluSc, HNRNPA1 overexpression induces U2AF2 crosslinking
near the 3′ end of the element compared to control cells (Supple-
mental Fig. 6A). Conversely, HNRNPA1 crosslinking globally de-
creases over Alu elements with overexpression (Supplemental
Fig. 6B,C; Supplemental Table 9). In contrast to U2AF2, crosslink-
ing of SRSF1 to antisense Alu elements shows no appreciable
changes (Supplemental Fig. 6D,E; Supplemental Table 9), suggest-
ing that the effect of HNRNPA1 is specific to U2AF2. In order
to asses any indirect effects of HNRNPA1 expression on known
regulators of U2AF2-Alu binding, we also measured protein levels
and cell localization of HNRNPC under control and overexpres-
sion of HNRNPA1, which showed no discernable changes (Sup-
plemental Fig. 7).
To determine if Alu elements exhibiting HNRNPA1-depen-
dent increases in U2AF2 crosslinking are located in cis relative
to annotated skipped exons (Alu elements upstream of or
downstream from a splicing event) or in trans (another locus)
(Supplemental Fig. 8), we compared the proportion of U2AF2
crosslinks within Alu-elements relative to sequences flanking
annotated as alternative cassette (skipped) exons in control or
HNRNPA1 overexpression cells. The scatter plot shown in Figure
4C (data in Supplemental Tables 10 and 11) demonstrates that
the proportion of U2AF2 crosslinks present in Alu elements
increases significantly upon HNRNPA1 overexpression, whereas
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Figure 3. HNRNPA1 induced redistribution of U2AF2 crosslinking near
3′ss. (A,B) Normalized crosslinking distribution for U2AF2 in wild-type
(blue line) and HNRNPA1 overexpression cell lines (red line) with 95% con-
fidence interval (gray area). Data are divided between constitutive (A) and
alternative cassette (B) exons. (C) Distribution of U2AF2 crosslinking
changes within 200-bp intron regions near 3′ss of alternative cassette ex-
ons. Gray bars correspond to annotated alternative splicing events with no
evidence of HNRNPA1 crosslinking in either condition, and pink represents
annotated events with detectable HNRNPA1 crosslinking.
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the proportion of HNRNPA1 crosslinks is decreased (Supplemental
Fig. 6C; data in Supplemental Tables 12 and 13). Additionally,
distribution of distal intronic U2AF2 peaks showing increases
with HNRNPA1 overexpression show a significant enrichment
for Alu elements compared to a null distribution (Supplemental
Fig. 9). In contrast, the proportion of SRSF1 crosslinks to Alu
elements is refractory to changes in HNRNPA1 expression levels
(Supplemental Fig. 6E; data in Supplemental Tables 14 and 15).
These data demonstrate a global change in U2AF2-Alu association
and refute the hypothesis that a few spurious Alu elements are
responsible for the signal observed in Figure 4A. To determine if
cis-Alu elements are involved in HNRNPA1-regulated alternative
splicing, we manually curated the list of 83 splicing events that
also had detectable U2AF2 crosslinking. We found that 41% of
HNRNPA1-dependent exon skipping events exhibited redistribu-
tion of U2AF2 to adjacent Alu elements (Table 1). Taken together,
these data demonstrate that overexpression ofHNRNPA1 influenc-
es the association of U2AF2 with both sense and antisense Alu
elements.
Alu elements influence alternative
splicing, although the mechanisms are
poorly understood (Sorek et al. 2002;
Lev-Maor et al. 2008; Gal-Mark et al.
2009; Schwartz et al. 2009; Pastor and
Pagani 2011). Splicing regulatory ele-
ments often exhibit position-dependent
and context-dependent functions (Fu
and Ares 2014). To determine if Alu-
elements with HNRNPA1-dependent
changes in U2AF2 crosslinking exhibit
positional bias, we measured their dis-
tance relative to the 3′ss of constitutive
or skipped exons. In general, we observed
that Alu elements are closer to skipped
exons than constitutive exons (P = 1.4 ×
10−46, Wilcoxon rank-sum test) (Fig.
4D, cf. blue and orange boxes). But yet,
those Alu elements with HNRNPA1-
dependent increases in U2AF crosslink-
ing are significantly closer to exons
than those that are unchanged (P =
9.5 × 10−92) (Fig. 4D). Taken together,
our data suggest that Alu-elements may
function as cis-regulatory elements that
compete with authentic exons for bind-
ing to splicing factors.
To determine if changes in U2AF2
crosslinking correlated with HNRNPA1-
dependent splicing regulation, we se-
quenced poly(A)+ selected RNA libraries
from control and HNRNPA1 overexpres-
sion cells (Supplemental Table 16). Of
the 267 HNRNPA1-regulated cassette
exons that exhibited at least a 33%
change in splicing (Bayes factor >10),
the majority exhibited increased levels
of exon skipping upon HNRNPA1 over-
expression (Fig. 5A; Supplemental Table
17). Eighty-three of the 267 differentially
spliced exons also had detectable U2AF2
crosslinking proximal to 3′ss in either
control or HNRNPA1-overexpressing
cell lines.Of those 83 exons,∼90%exhibited anHNRNPA1-depen-
dent increase in exon skipping compared to ∼70% of exons with
no detected U2AF2 crosslinking (P < 0.0025, Fisher’s exact test)
(Table 1). To investigate the relationship between exon skipping
with loss or gain of U2AF2 crosslinking, we increased the sensitiv-
ity of our analysis by using less stringent thresholds for differential
splicing (difference >1%, Bayes factor >5) (Supplemental Table 18).
This resulted in 574 events, the majority of which favored exon
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Figure 4. HNRNPA1 overexpression correlates with global redistribution of U2AF2 signal to Alu RNA
elements. (A) Aggregated crosslinking sites on antisense Alu elements and nearby regions for U2AF2.
Blue represents wild-type binding of the given RNA binding protein, and red represents HNRNPA1 over-
expression of the log10 number of iCLIP read counts across all antisense-Alu elements. (B) Aggregated
crosslinking sites on sense Alu elements and nearby regions for U2AF2. (C) Scatter plot of all human cas-
sette exons measuring the proportion of U2AF2 iCLIP crosslinking sites found within Alu elements within
the cassette exon event over the total number of crosslinks foundwithin the event. Proportions from con-
trol andHNRNPA1 overexpression samples are compared for each individual cassette exon event. (D) Box
plot representing the distance of Alu elements from cassette exons (blue) and constitutive exons (orange)
that show no change in U2AF2 crosslinking versus those that show an increase in U2AF2 crosslinking.
Table 1. Summary of HNRNPA1-dependent changes in exon skip-
ping with detectable U2AF2 crosslinking
Total no.
of events
U2AF2
crosslinking
No U2AF2
crosslinking
HNRNPA1-dependent
exon inclusion
59 9 50
HNRNPA1-dependent
exon skipping
208 74 134
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skipping (424 events). Exon skipping events that also had evidence
of HNRNPA1 crosslinking in either condition were enriched
for loss of U2AF2 crosslinking as compared to events with no
detectable HNRNPA1 crosslinking (P < 0.026 Fisher’s exact test)
(Table 2). In some cases, HNRNPA1-sensitive exons exhibi-
ted redistribution of U2AF2 signal from near 3′ss to distal, up-
stream crosslinking sites, suggesting their possible function in
HNRNPA1-mediated splicing regulation (Fig. 5E; Supplemental
Figs. 10–20). We use transient transfection of T7 epitope–tagged
HNRNPA1 and RT-PCR to validate several endogenous splicing
events exhibiting HNRNPA1-dependent reduction in U2AF2-3′ss
crosslinking (Fig. 5B–D, upper panels). As expected, we observed
a significant reduction in exon inclusion for ACIN1, SRSF6, and
TRNAU1AP in HNRNPA1 overexpression cells relative to the con-
trol (Fig. 5B–D, lower panels).
To determine if noncanonical U2AF2 binding sites are invol-
ved in HNRNPA1-dependent exon skipping, we created matched
pairs of hemoglobin subunit beta (HBB) splicing reporter gene con-
structs (Rothrock et al. 2003) containing the wild-type or mutated
intronic elements upstream of the HNRNPA1-sensitive exons
found in the SRSF6pre-mRNA (Fig. 5E). The SRSF6 splicing reporter
constructs were cotransfected into HEK293T cells with epitope-
tagged HNRNPA1 expression plasmid or a control plasmid
(Fig. 5F). Because inclusion of the test exons may induce non-
sense-mediated decay (NMD) by inducing an in-frame premature
termination codon (PTC), as is the case with SRSF6, we assayed
splicing in the presence of the translation inhibitor emetine
dihydrochloride, a potent inhibitor of NMD in vivo (Noensie
and Dietz 2001; Lareau et al. 2007; Ni et al. 2007). As shown in
Figure 5H, RT-PCR of wild-type SRSF6 splicing reporters show ex-
pected decrease in exon inclusion in response to HNRNPA1 over-
expression compared to endogenous levels (Fig. 5G). Deletion of
the distal intronic U2AF2 binding site resulted in an attenuation
of exon inclusion and a loss of HNRNPA1-dependent exon
skipping. Quantification of amplicon ratios demonstrated that
mutation of the putative HNRNPA1-induced, U2AF2-associated
intronic elements disrupt splicing sensitivity to HNRNPA1 over-
expression (P < 0.0029, respectively, ratio paired t-test) (Fig. 5I).
Discussion
In this study, we have used iCLIP to study the impact of perturba-
tion of alternative splicing factor levels on core components of the
spliceosome. These experiments allow for quantitative analysis
of competitive RNA binding and splice site recognition on a
global scale. In cells overexpressing HNRNPA1, we observed a pro-
nounced shift in U2AF2 binding sites relative to control cells.
Based on U2AF2 peak distributions, this HNRNPA1-dependent
redistribution involves loss of proximal-intron and recognition
of distal-intronic peaks (Figs. 1, 2A–C). A similar pattern was
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Figure 5. Noncanonical U2AF2 binding sites influence HNRNPA1-de-
pendent exon skipping. (A) Bar graph of all HNRNPA1-dependent splicing
changes as detected by MISO analysis. Events determined from the com-
parison of RNA-seq data derived from HNRNPA1 overexpressing HEK293T
cell versus control HEK293T cells. (B–D) Sashimi plots showing read and
junction coverage for three genes: ACIN1, SRSF6, and TRNAU1AP. Virtual
gel representation of an Agilent 2100 Bioanalyzer DNA 1000 assay of
RT-PCR products corresponding to endogenous ACIN1, SRSF6, and
TRNAU1AP from control and HNRNPA1 overexpression cells (lower left pan-
el). Bar graph depicting mean exon inclusion for TRNAU1AP and SRSF6
splicing reporters quantified using an Agilent 2100 Bioanalyzer with stan-
dard deviation bars. (∗) P < 0.05; (∗∗) P < 0.01 (lower right panel). (E) UCSC
Genome Browser screen shot of U2AF2 iCLIP read coverage at the SRSF6
exon 3 locus in control or HNRNPA1 overexpression cells (bottom and
top three tracks, respectively). Peaks called by CLIPper are depicted below
the coverage tracks. Red box denotes the 3′ss of SRSF6 exon 3. (F ) Splicing
reporter constructs created representing wild-type (Wt) or mutant (Mt)
versions of alternative exons in SRSF6. Noncanonical U2AF2 binding
sites in SRSF6 were mutated (red lines) by deletion. GloE1, GloE2, and
GloE3 designate exons 1–3 of beta-globin. The polyadenylation signal
from the bovine growth hormone 1 gene is indicated by bGH pA. (G)
Representative western blots probed with antibodies against HSP90,
HNRNPA1, and the T7 epitope. Lysates were prepared from HEK293T
cells transiently transfected with either wild-type (WT) or mutant (MT)
SRSF6 reporter construct and control or T7 epitope–tagged HNRNPA1.
(H) Virtual gel representation of an Agilent 2100 Bioanalyzer DNA 1000
assay of RT-PCR products from SRSF6 splicing construct transfections.
(I) Bar graph depicting mean exon inclusion for SRSF6 splicing reporters
quantified using an Agilent 2100 Bioanalyzer with standard deviation
bars. (∗) P < 0.05.
Table 2. Summary of HNRNPA1-dependent changes in exon skip-
ping and U2AF2 positioning
HNRNPA1 crosslinking
>1 cpm
No detectable
HNRNPA1 crosslinking
Increased
U2AF2
Decreased
U2AF2
Increased
U2AF2
Decreased
U2AF2
Exon inclusion 1 0 11 18
Exon skipping 3 11 74 64
Howard et al.
694 Genome Research
www.genome.org
observed at the single nucleotide level, where U2AF2 crosslinking
density near alternative 3′ss was reduced in HNRNPA1 overexpres-
sion cells and distributed across exons (Fig. 3). In addition to
evidence for global changes in U2AF2 binding position, we also
observed variation in sequence motifs enriched at U2AF2 peaks
in both cell lines (Figs. 1, 2E). Splicing reporter assays revealed
that upstream polypyrimidine tracks identified by iCLIP were
involved in HNRNPA1-dependent splicing regulation (Fig. 5).
These data also support the hypothesis that distant U2AF2 binding
sites may function as splice site decoys that contribute to
HNRNPA1-dependent splicing silencing.
HNRNPA1 represses splicing through diverse mechanisms.
We think our data suggest that HNRNPA1 alters the competition
between bona fide and decoy 3′ss. Because HNRNPA1 forms a ter-
nary complex with the U2AF heterodimer and the 3′ss (Tavanez
et al. 2012), HNRNPA1-dependent redistribution of U2AF2 from
bona fide splice sites to “decoy” sites might arise from direct com-
petition for these splicing factors at 3′ss. Tavanez et al. (2012) also
demonstrated that HNRNPA1 is required for discrimination of AG
and CG dinucleotides at 3′ss. HNRNPA1 displaces U2AF fromnon-
canonical CG-containing splice sites but allows it to productively
engage AG-containing splice sites. We observed a global decrease
in U2AF2 crosslinking near alternative 3′ss, but little change near
constitutive splice sites. Given that alternative exons are typically
flanked by weak splice sites, it seems unlikely that this proofread-
ing mechanism contributes to regulation of alternative splicing.
Tavanez et al. (2012) also noted that depletion of HNRNPA1
from HeLa cells resulted in increased U2AF association at spurious
sites, including within the 3′ UTRs of intronless messages when
HNRNPA1 is knocked down. We also observed a global increase
in U2AF2 crosslinking to 3′ UTRs but not CDS regions when
HNRNPA1 is overexpressed (Supplemental Table 3). It will be
important to understand if RNA determinants (sequence, struc-
ture, splice site strength) distinguish between a proofreading
function for HNRNPA1 and a simple competition with U2AF
(Jain et al. 2017).
Our findings are well aligned with a recent census of U2AF2
binding sites in HeLa cells, which documented a position-depen-
dent code for U2AF2 in splicing regulation (Shao et al. 2014).
Perhaps most relevant to the work presented here is their observa-
tion that noncanonical U2AF2 binding sites located upstream or
within alternative exons correlate with exon skipping (Lim et al.
2011; Shao et al. 2014; Cho et al. 2015). We find strong evidence
for an HNRNPA1-dependent shift in U2AF2 binding sites from
exon-proximal to -distal intronic positions. We have demonstrat-
ed that a noncanonical U2AF2 binding site in SRSF6 intron 2 is
required for HNRNPA1-dependent splicing regulation (Fig. 5E).
Additionally, in the context of a splicing reporter, deletion of
this element appears to dramatically reduce exon inclusion. It is
possible thatHNRNPA1-dependent eviction of U2AF2 at 3′ss could
initiate remodeling at other functional RNA elements, such as
nearby intronic splicing enhancers.
Our results suggest a role forHNRNPA1 in promoting recogni-
tion of noncanonical sites by U2AF2. One interesting observation
is that although U2AF2 binding sites are predominantly pyrimi-
dine-rich motifs (Singh et al. 1995), we observe variation in over-
represented sequence motifs at different classes of binding sites
across the transcriptome, suggesting that U2AF2 occupies low-
affinity binding sites when HNRNPA1 is overexpressed (Fig. 2E).
This result is consistent with the hypothesis that U2AF2 and
HNRNPA1 compete for closely related sequences (Zhu et al.
2001; Okunola and Krainer 2009; Jain et al. 2017). Alternatively,
HNRNPA1may modulate U2AF2 RNA binding specificity by alter-
ing the conformation of its RNA recognition motifs (Mackereth
et al. 2011; Tavanez et al. 2012; Agrawal et al. 2016; Voith von
Voithenberg et al. 2016). It is possible that the large-scale reorgani-
zation of U2AF2 binding to Alu-derived RNA sequences triggered
by HNRNPA1 overexpression is an ultrasensitive response driven
by molecular titration of U2AF–3′ss interactions by HNRNPA1
(Zhang et al. 2013).
Alu elements influence gene expression in diverse ways
(Hasler and Strub 2006; Chen and Carmichael 2009; Gong and
Maquat 2011; Pastor and Pagani 2011; Kelley et al. 2014; Tajnik
et al. 2015). Recently, Zarnack et al. (2013) demonstrated that
HNRNPC competes with U2AF2 to repress inclusion of antisense
Alu-derived exons in mRNA. We find that HNRNPA1 overexpres-
sion correlates with increased U2AF2 association with both sense
and antisense Alu-derived RNA sequences. We did not observe
any change in HNRNPC protein expression or localization
(Supplemental Fig. 7). Taken together, our data demonstrate that
Alu-derived sequences may function as RNA regulatory elements
that respond to changes to the intracellular concentration of splic-
ing factors. It is possible that, as primate-specific elements, Alu
elements may influence the evolution of splicing regulation by
modulating recognition of bona fide exons. Our results suggest
the intriguing hypothesis that Alu-derived RNA elements may
contribute to species-specific differences in alternative splicing
throughout the primate lineage.
Methods
iCLIP analysis of U2AF2, SRSF1, and HNRNPA1
iCLIP was performed as previously described (Konig et al. 2010;
Huppertz et al. 2014). Briefly, Flp-In T-REx HEK293T cells
(Invitrogen) lacking or containing a stable, inducible T7-tagged
version of HNRNPA1 were treated with tetracycline for 24 h and
then irradiated with UV-C light to form covalent crosslinks be-
tween proteins and nucleic acids in vivo. After cell lysis, RNA
was partially fragmented using low concentrations of micrococcal
nuclease, and U2AF65–, SRSF1–, or HNRNPA1–RNA complexes
were immunopurified with U2AF65, (MC3; Santa Cruz
Biotechnology), SRSF1 (96; Santa Cruz Biotechnology), and
HNRNPA1 (4B10; Santa Cruz Biotechnology) antibodies immobi-
lized on protein A–coated magnetic beads (Life Technologies), re-
spectively. After stringent washing and dephosphorylation (Fast
AP, Fermentas), RNAswere ligated at their 3′ ends with a preadeny-
lated RNA adaptor (Bioo Scientific) and radioactively labeled to al-
low visualization. Samples were run usingMOPS-based protein gel
electrophoresis (in-house recipe) and transferred to a nitrocellulose
membrane. Protein–RNA complexes migrating 15–80 kDa above
free protein were cut from the membrane, and RNAwas recovered
from the membrane by proteinase K digestion under denaturing
(3.5Murea) conditions. The oligonucleotides for reverse transcrip-
tion contained two inversely oriented adaptor regions adapted
from the Bioo NEXTflex small RNA library preparation kit (Bioo
Scientific), separated by a BamHI restriction site aswell as a barcode
region at their 5′ end containing a 4-nt experiment-specific bar-
code within a 5-nt random barcode to mark individual cDNAmol-
ecules. cDNAmolecules were size-purified using denaturing PAGE
gel electrophoresis, circularized by CircLigase II (Epicenter), an-
nealed to an oligonucleotide complementary to the restriction
site, and cut using BamHI (NEB). Linearized cDNAs were then
PCR-amplified using ImmoMix PCR master mix (Bioline) with
primers (Bioo) complementary to the adaptor regions and were
subjected to high-throughput sequencing using Illumina HiSeq.
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A more detailed description of the iCLIP protocol has been pub-
lished (Huppertz et al. 2014).
Mapping and analysis of iCLIP sequencing data
Single-end reads generated by Illumina HiSeq were inspected for
the presence of adaptor sequences. Reads containing sequences
corresponding to the 3′ RNA adaptor were retained if they were
at least 30 bp long after the adaptor sequence was trimmed off.
The first 9 bp in each read from the iCLIP library preparation, con-
taining an internal barcode comprising 4 bp for replicate identifi-
cation and 5 bp of random nucleotides for use in duplicate
mapping removal, were also removed before mapping. Trimmed
reads were checked for mapping to a repeat filter comprising
RepeatMasker elements (Tarailo-Graovac and Chen 2009) in the
human genome using Bowtie 2 (Langmead and Salzberg 2012).
Reads that passed the repeat filter were mapped to the transcrip-
tome and genomewith TopHat2 (Kim et al. 2013). If readsmapped
equally well to multiple loci, a single mapping was selected ran-
domly by TopHat2. Duplicate mappings from each replicate were
reduced to one per position if they had the same genomic end-
points and if they originated from reads with the same set of ran-
dom 5-bp nucleotides. Followingmapping and duplicate removal,
individual readswere truncated to their 5′ ends to represent the site
of crosslinking consistent with the iCLIP methodology. For all
samples, only such crosslinking sites found to have nonzero
mapping counts in two out of three replicates (or two out of two
duplicates where applicable) were considered to be biologically
reproducible candidates for further analysis. The counts at such re-
producible crosslinking sites were summed over all replicates to
create an aggregated data set for each cell condition and CLIP. To
determine the background from the iCLIP data sets, the two cell
conditions (control and HNRNPA1-overexpressing) were tempo-
rarily further aggregated for each CLIP (U2AF, SF2, A1), and those
binding sites that had nonzero counts in all three temporary aggre-
gate data sets were determined. A 41-nt mask was created by ex-
tending 20 nt upstream of and 20 nt downstream from each
such three-way common binding site. The aggregated data set of
binding sites for each cell condition and CLIP was then filtered
using this mask, keeping only sites outside the mask that also
had a mapping count of at least three in the aggregate data.
These aggregated and filtered data were used for downstream anal-
yses. This aggregation and filtering strategy was adapted from pre-
viously described iCLIP analysis pipelines (Friedersdorf and Keene
2014; Flynn et al. 2015). For use as input to CLIPper (Lovci et al.
2013), the filtered (single nucleotide) binding sites were expanded
by 15 nt upstream and 15 nt downstream.
CLIPper (CLIP-seq peak enrichment; https://github.com/
YeoLab/CLIPper) was used to determine genomic distribution of
RNA crosslinking peaks as well as identify clusters representing
binding sites for HNRNPA1, U2AF2, and SRSF1 for each condition
as previously described (Lovci et al. 2013). For each condition, the
resulting iCLIP peak data of the replicates were merged. The peaks
were annotated to the human genome (hg19) and then divided
into categories based on their genomic locations, including CDS,
intron, andUTR. The peaks in each categorywere further subsetted
based on whether they overlapped with Alu elements. For the
motif analysis, 50-bp sequences were extracted from the peak re-
gions (crosslinking site ± 25 bp). Strand-specific MEME-ChIP and
HOMER analyses were performed on these sequences to find
6–10 bp long, or 5-, 7-, 9-, and 11-bp enriched motifs (Bailey
et al. 2009; Heinz et al. 2010).
For differential crosslinking analysis, CLIPper peaks from
both control and HNRNPA1-overexpressing cells were merged
using BEDTools intersect, and peak coverage by crosslink-centered
reads (i.e., reads constructed by expanding the 5′ end upstream
and downstream by 15 nt) was assessed for all replicates using
BEDTools multicov (Quinlan and Hall 2010). Differential status
was subsequently determined using DESeq2 (Love et al. 2014).
Peaks were determined to be increasing (FDR < 0.05, log2(fold-
change) > 1) or decreasing (FDR < 0.05, log2(fold-change) <−1)
based on FDR and log2(fold-change). These categories were further
subdivided based on overlap of Alu elements, 3′ss (i.e., the 200-nt
intronic region proximal to the 3′ss), and other. Enriched motifs
were identified as described above using HOMER (Heinz
et al. 2010).
RBP binding analysis
We extracted 40,769 cassette exons from MISO human genome
(hg19) alternative events annotation version 2. We extracted
200,880 constitutive exons from RefSeq gene annotation by ex-
cluding the exons that overlap with cassette exons. Gene differen-
tial expression analysis was performed using edgeR (Robinson et al.
2010). We used 40,952 constitutive exons that were not signi-
ficantly differentially expressed (FDR > 0.05) in further analysis.
For each RNAbindingprotein in each cell line, the iCLIP reads
of all the replicates were merged together (Flynn et al. 2015). The
start positions of the reads were considered as crosslinking sites.
The number of reads near the 3′ss (100 bp into the intron, 50 bp
into the exon) of each exon was calculated based on a 10-bp win-
dow. The raw read counts were normalized by the total library size.
The changes in binding of U2AF2 and SF2 near 3′ss were fur-
ther analyzed with edgeR. Read counts were calculated for 200-bp
intron regions near the 3′ss of the cassette exons. For each RBP, the
regions with more than one count per million (CPM) in at least
half of the replicates in either of the cell line were used for binding
change analysis.
RBP binding near Alu elements
We extracted 315,974 antisense Alu elements from RepeatMasker.
The merged iCLIP data for each condition were down-sampled
to 1M reads. The total number of sense strand reads were cal-
culated for Alu and nearby regions (250 bp from Alu boundary).
For each cassette exon events (cassette exon + up-/downstream
introns + up-/downstream exons), the number of reads in antisense
Alu elements, and the total number of reads in thewhole eventwere
calculated separately. The proportion of reads that fall into anti-
sense Alu elements for each event was used to represent the RBP
binding change in Alu regions.
Randomization test for establishing significance of Alu-element
overlap by distal intronic increasing peaks
U2AF2 iCLIP peaks exhibiting increasing binding following
HNRNPA1 overexpression were extracted and subsetted for those
found within distal intronic regions using a series of different
distance constraints (minimum 200, 500, or 2000 bases from the
nearest exon). Any intronic region found to overlap an alternative
exon was removed from consideration (introns flanking the
alternative exon were included). The peaks were then randomly
shuffled within the same sets of distal intronic regions using
BEDTools shuffle, and the number of shuffled peaks overlapping
Alu elements was determined. The shuffling process was repeated
1000 times to construct a null distribution of expected Alu over-
laps. Finally, the actual number ofAlu-overlapping peaks was com-
pared to the randomized null distribution. As the observed counts
exceeded the entirety of the null distribution of counts for each
definition of distal intron, the P-value has an upper bound of
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0.001 for each comparison. The analysis was repeated for peaks
found in corresponding proximal intronic regions and exons.
mRNA-seq of control or HNRNPA1-overexpressing HEK293 cells
RNA was isolated from whole-cell lysates of control and
HNRNPA1-overexpressing Flp-In T-REx HEK 293T cells using
TRI-Reagent LS (Sigma). Poly(A)+ sequencing libraries were pre-
pared using the TrueSeq RNA library prep kit (Illumina). Each
condition was analyzed in duplicate using the HiSeq 2000.
Quantification of alternative splicing by RNA-seq
poly(A)+ transcriptome sequencing reads were mapped to the
human reference genome (hg19) with TopHat2. Mapped reads of
duplicates were merged together for splicing analysis. Splicing
changewas analyzedwithMISO (Katz et al. 2010). TheMISO result
was filtered with the following parameters: --num-inc 1 --num-exc
1 --num-sum-exc 10 --delta-psi 0.20 --bayes-factor 10. After filter-
ing, 267 skipped exon events were left for further analysis. We
chose to map our data to hg19 to facilitate analysis with the
MISO alternative splicing event database, which is based on
hg19 annotation. Because our study focuses on alternative splicing
of protein-coding genes, remapping the data to GRCh38 will not
have a significant impact on rigor or reproducibility.
Mapping to an Alu consensus sequence
Alu element annotations were obtained from the hg19 UCSC
Genome Browser RepeatMasker track. A strategy similar to the one
described in Jacobs et al. (2014) was used to show the CLIPper peak
density over all Alu elements as follows: After removal of the lon-
gest 2%, the top 50 longest human Alu sequences were aligned
with MUSCLE and used to construct a consensus sequence
(Edgar 2004). CLIPper peaks were mapped from the genomic posi-
tion to the consensus sequence position using a BLAT alignment
of the repeat to the consensus, and the coverage of summits
per bp of the consensus AluSc was plotted in Supplemental
Figure 5c (Kent 2002). A Genome Browser session display-
ing the Repeat Masker Data can be found at the following URL:
http://genome.ucsc.edu/cgi-bin/hgTracks?hgS_doOtherUser=
submit&hgS_otherUserName=Max&hgS_otherUserSessionName=
pubRepeats2Sanford.
Data access
All iCLIP and RNA-seq data generated in this study have been
submitted to the NCBI Gene Expression Omnibus GEO (GEO;
https://www.ncbi.nlm.nih.gov/geo/) under accession number
GSE83923. Access to other publicly available data sets from GEO
used in this study is detailed in Supplemental Table S8.
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